Panel reactive HLA antibodies, soluble CD30 levels, and acute rejection six months following renal transplant-Reference-Cited by-同舟云学术

Panel reactive HLA antibodies, soluble CD30 levels, and acute rejection six months following renal transplant

Published:2010-11 Issue:6 Volume:24 Page:821-829
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:

Author:

Domingues Elizabeth M.F.L.,Matuck Teresa,Graciano Miguel L.,Souza Edison,Rioja Suzimar,Falci Mônica C.,Monteiro de Carvalho Deise B.,Porto Luís Cristóvão

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0012.2009.01182.x/fullpdf

Reference45 articles.

1. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays - single-center experience;Mihaylova;Hum Immunol,2006

2. Analysis of AHG-PRA and ELISA-PRA in kidney transplant patients with acute rejection episodes;Kaufman;Transpl Immunol,2003

3. Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression;Van Der Mast;Transplantation,2003

4. Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment;Mauiyyedi;Curr Opin Nephrol Hypertens,2002

5. Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction;Zhang;Transplantation,2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Serum Soluble CD30 Levels in Pediatric Kidney Transplant Recipients;South East European Journal of Immunology;2023-11-30

2. Soluble CD30, the Immune Response, and Acute Rejection in Human Kidney Transplantation: A Systematic Review and Meta-Analysis;Frontiers in Immunology;2020-02-28

3. Influence of immunosuppressive drugs on the CD30 molecule in kidney transplanted patients;Human Immunology;2018-07

4. Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations—When Is the Best Time to Measure?;Transplantation Proceedings;2018-04

5. Predictive Factors of Acute Rejection in Low Immunologic Risk Kidney Transplant Recipients Receiving Basiliximab;Transplantation Proceedings;2016-09